Market open

Recursion Pharmaceuticals/RXRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Recursion Pharmaceuticals

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Ticker

RXRX
Trading on

Industry

Biotechnology

Employees

500

RXRX Metrics

BasicAdvanced
$1.9B
Market cap
-
P/E ratio
-$1.64
EPS
0.83
Beta
-
Dividend rate
$1.9B
0.83
$15.74
$4.97
5.1M
6.068
5.54
12.518
15.378
-773.49%
-34.25%
-71.18%
30.859
3.23
3.82
-4.432
-0.70%
19.76%
77.82%
-11.89%

What the Analysts think about RXRX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Recursion Pharmaceuticals stock.

RXRX Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

RXRX Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy RXRX

$

Sign up or log in to buy
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Recursion Pharmaceuticals stock?

Recursion Pharmaceuticals (RXRX) has a market cap of $1.9B as of October 15, 2024.

What is the P/E ratio for Recursion Pharmaceuticals stock?

The price to earnings (P/E) ratio for Recursion Pharmaceuticals (RXRX) stock is 0 as of October 15, 2024.

Does Recursion Pharmaceuticals stock pay dividends?

No, Recursion Pharmaceuticals (RXRX) stock does not pay dividends to its shareholders as of October 15, 2024.

When is the next Recursion Pharmaceuticals dividend payment date?

Recursion Pharmaceuticals (RXRX) stock does not pay dividends to its shareholders.

What is the beta indicator for Recursion Pharmaceuticals?

Recursion Pharmaceuticals (RXRX) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.